PARTHENON CAPITAL PARTNERS
PARTHENON CAPITAL PARTNERS is a Series C+, growth-equity and buyout fund in the US writing $100M–$500M checks into Fintech, healthcare-solutions and business-and-technology-services.
- Stages
- Series C+, growth-equity, buyout
- Sectors
- Fintech, healthcare-solutions, business-and-technology-services
- Check size
- $100M–$500M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 1998
- Assets under management
- $13.8B
- Website
- parthenoncapital.com
Thesis
Parthenon Capital Partners is a private equity firm founded in 1998, managing over $13.8 billion in AUM. Headquartered in Boston, MA, with offices in San Francisco, CA, and Austin, TX, they focus on middle-market companies in financial services, healthcare solutions, and business and technology services. Their investment thesis is research-driven and thematic, targeting high-growth niches often characterized by complex regulatory structures or technological disruption. They typically invest between $100 million and $500 million in equity for platform companies, with the capacity for larger deals over $1 billion through LP co-investments. The firm also engages in other investment strategies beyond growth equity and buyouts.
Common questions
Does PARTHENON CAPITAL PARTNERS invest at the Series C+ stage?
Yes. PARTHENON CAPITAL PARTNERS lists Series C+, growth-equity and buyout among the stages it invests in.
What check size does PARTHENON CAPITAL PARTNERS write?
PARTHENON CAPITAL PARTNERS writes $100M–$500M checks.
Where does PARTHENON CAPITAL PARTNERS invest?
PARTHENON CAPITAL PARTNERS invests in the US.